Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China
· Delayed Price · Currency is CNY 99.85
-0.26 (-0.26%)
Last updated: Jul 9, 2025
SHA:688198 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '25 Jul 8, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| 13,719 | 14,977 | 17,008 | 17,502 | 24,524 | 7,455 | Upgrade
| |
Market Cap Growth | -1.49% | -11.94% | -2.82% | -28.63% | 228.95% | 84.25% | Upgrade
|
Enterprise Value | 13,516 | 14,590 | 16,535 | 16,744 | 23,773 | 6,722 | Upgrade
|
Last Close Price | 99.85 | 108.18 | 122.68 | 126.51 | 177.61 | 54.18 | Upgrade
|
PE Ratio | 79.61 | 102.35 | 147.63 | 183.98 | 479.01 | 131.89 | Upgrade
|
Forward PE | 62.41 | 72.92 | 104.25 | 104.25 | 238.22 | - | Upgrade
|
PS Ratio | 26.09 | 29.84 | 45.89 | 59.30 | 97.39 | 40.98 | Upgrade
|
PB Ratio | 10.69 | 11.98 | 14.31 | 15.92 | 24.82 | 8.92 | Upgrade
|
P/TBV Ratio | 11.85 | 13.34 | 15.68 | 16.57 | 25.92 | 9.00 | Upgrade
|
P/FCF Ratio | 934.06 | - | 1356.96 | 728.83 | 5741.55 | 173.10 | Upgrade
|
P/OCF Ratio | 88.16 | 109.94 | 120.49 | 135.83 | 320.60 | 146.86 | Upgrade
|
EV/Sales Ratio | 25.71 | 29.07 | 44.61 | 56.73 | 94.41 | 36.95 | Upgrade
|
EV/EBITDA Ratio | 70.33 | 96.98 | 149.37 | 190.74 | 656.86 | 127.58 | Upgrade
|
EV/EBIT Ratio | 80.72 | 111.26 | 166.17 | 203.78 | 787.92 | 142.96 | Upgrade
|
EV/FCF Ratio | 920.24 | - | 1319.18 | 697.26 | 5565.71 | 156.07 | Upgrade
|
Debt / Equity Ratio | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | - | Upgrade
|
Debt / EBITDA Ratio | 0.21 | 0.06 | 0.11 | 0.02 | 0.04 | - | Upgrade
|
Debt / FCF Ratio | 2.69 | - | 0.98 | 0.06 | 0.39 | - | Upgrade
|
Asset Turnover | 0.38 | 0.36 | 0.30 | 0.27 | 0.27 | 0.22 | Upgrade
|
Inventory Turnover | 1.25 | 1.34 | 1.13 | 1.17 | 1.55 | 1.49 | Upgrade
|
Quick Ratio | 3.32 | 4.45 | 7.75 | 10.66 | 22.23 | 25.73 | Upgrade
|
Current Ratio | 5.41 | 5.17 | 8.43 | 11.45 | 23.31 | 26.30 | Upgrade
|
Return on Equity (ROE) | 12.78% | 10.84% | 9.56% | 9.04% | 5.62% | 6.99% | Upgrade
|
Return on Assets (ROA) | 7.52% | 5.94% | 4.96% | 4.65% | 1.98% | 3.54% | Upgrade
|
Return on Capital (ROIC) | 8.27% | 6.66% | 5.40% | 4.91% | 2.07% | 3.67% | Upgrade
|
Return on Capital Employed (ROCE) | 12.30% | 10.00% | 8.00% | 7.40% | 3.00% | 5.60% | Upgrade
|
Earnings Yield | 1.24% | 0.98% | 0.68% | 0.54% | 0.21% | 0.76% | Upgrade
|
FCF Yield | 0.11% | -0.18% | 0.07% | 0.14% | 0.02% | 0.58% | Upgrade
|
Dividend Yield | 0.80% | 0.74% | 0.65% | 0.40% | 0.20% | 0.26% | Upgrade
|
Payout Ratio | 64.08% | 74.67% | 58.88% | 50.69% | 37.51% | 33.97% | Upgrade
|
Buyback Yield / Dilution | 2.42% | 0.29% | -0.92% | -0.86% | -0.44% | -33.66% | Upgrade
|
Total Shareholder Return | 3.22% | 1.03% | -0.27% | -0.47% | -0.24% | -33.40% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.